ARCHIVES

Xeloda-Eloxatin Study Updated; Phase III Trial Interim Analysis

This article is from The Cancer Letter archive.

Vol. 25 No. 12 | December 27, 2002

Download PDF Visit The Full Archive

Related Articles

Also in this 12-page issue: ASCO urges freeze of Medicare payments for chemotherapy at 2004 levels for next two years.

February 20, 2004

Onward to 2010? NCI promises faster progress for more money.

May 20, 2005

Senate Approves $1 Billion For NCI

July 27, 1979

Three Institutes To Test BioMicro’s Microarray Product. GlycoDesign Allowed Patent For Cancer Drug GD0039.

March 1, 2002

DHEA- Sulfate Said To Prevent Breast Cancer, Overweight

March 28, 1980

MSKCC hopes to raise $1 billion in five-year campaign.

November 7, 2003